Explain absorption of monosaccharide
monosaccharide absorption intestinal enterocyte glucose transport

A pathophysiology diagram illustrating the mineral absorption mechanisms within the intestinal lumen and enterocyte, specifically focusing on zinc (Zn/Zn+2). The diagram delineates three primary pathways for ingested minerals. 1) Organic absorption: Zinc (Zn) complexed with amino acids (AA) utilizes a specific Amino Acid Transporter on the enterocyte membrane, leading to successful absorption. 2) Inorganic absorption: Free ionic zinc (Zn+2) utilizes a dedicated Inorganic Metal Transporter to enter the enterocyte. 3) Non-absorption: Ionic zinc (Zn+2) that remains free or interacts with dietary antagonists (e.g., phytates or oxalates, labeled as 'Antagonist') fails to be transported, resulting in a 'Not Absorbed' outcome. The visual contrasts the efficiency of chelated organic minerals versus inorganic forms and highlights the role of competitive inhibition by antagonists. Key anatomical landmarks include the lumen and the apical membrane of the enterocyte. This illustration serves educational purposes in gastroenterology and clinical nutrition regarding bioavailability and trace element metabolism.

This pathophysiology diagram illustrates the mechanism of action for ferric maltol, an oral iron-replacement therapy. The visual depicts the intestinal lumen containing ferric maltol complexes, shown as clusters of one red ferric iron (Fe3+) sphere bound to three purple maltol spheres. The diagram outlines the transport process across an enterocyte, characterized by its brush border. At the apical membrane, the 'iron transporter mechanism' dissociates the complex, allowing Fe3+ to enter the cell while maltol is released. Once inside the enterocyte, iron is either stored in a star-shaped ferritin complex or exported via ferroportin 1 into the basolateral space. In the systemic circulation, iron (depicted as Fe2+) binds to transferrin for transport to the liver and bone marrow. Key annotations emphasize that the uptake is saturable, which helps avoid iron overload, and that the maltol component is eliminated via the kidneys. This educational illustration is designed for medical students and clinicians to understand iron pharmacokinetics and gastrointestinal absorption pathways.

A two-part schematic diagram detailing the preparation and absorption mechanism of paclitaxel-loaded polymeric micelles for oral delivery. (A) Preparation phase: Illustrates the synthesis of PTX-loaded LC-SA/CS-SA micelles using the solvent evaporation-hydration method. Individual components including Chitosan-Stearic acid (CS-SA), L-carnitine-Stearic acid (LC-SA), and paclitaxel molecules are shown self-assembling into a spherical micelle structure with a hydrophobic core and a functionalized outer shell. (B) Absorption mechanism: Depicts the intestinal transport of intact micelles from the intestinal lumen across the enterocyte membrane. The process is facilitated by carnitine/organic cation transporters (OCTN2), represented by oval docking sites on the brush border. Following transepithelial transport, the micelles enter the bloodstream where they undergo hydrolysis, releasing the encapsulated paclitaxel along with stearic acid, L-carnitine, and chitosan components. This illustration demonstrates a targeted drug delivery strategy to improve the bioavailability of lipophilic drugs like paclitaxel via the carnitine transporter pathway.
![This diagnostic image displays comparative microPET scans showing the distribution of 2-deoxy-2-[18F]fluoro-D-glucose (2-FDG) in wild-type and Glut2–/– mouse models. Coronal (c) and sagittal (s) sections are presented for each genotype 60 minutes after orogastric gavage. Tracer activity is visualized using a pseudocolor intensity scale where red represents maximum activity and purple represents minimum activity. Key anatomical volumes of interest (VOIs) are delineated and labeled: brain (br), heart (h), stomach (st), intestine (in), and urinary bladder (bl). In both models, high activity is visible in the bladder (bl) and brain (br). A significant comparative finding is the high 2-FDG retention in the stomach (st) of the Glut2–/– mice (indicated by intense red/orange coloration) compared to the wild-type, suggesting impaired gastric emptying or altered glucose transport. The scans illustrate the physiological processes of gastric emptying and intestinal absorption, emphasizing the role of GLUT2 in glucose pharmacokinetics and metabolic distribution.](/_next/image?url=https%3A%2F%2Fcdn.orris.care%2Fcdss_images%2Fpmc_clinical_VQA_798c14e2460242ed1996ae958fe494fdb35feebcde70caff9c7171962ac3f2fe.jpg&w=3840&q=75)
This diagnostic image displays comparative microPET scans showing the distribution of 2-deoxy-2-[18F]fluoro-D-glucose (2-FDG) in wild-type and Glut2–/– mouse models. Coronal (c) and sagittal (s) sections are presented for each genotype 60 minutes after orogastric gavage. Tracer activity is visualized using a pseudocolor intensity scale where red represents maximum activity and purple represents minimum activity. Key anatomical volumes of interest (VOIs) are delineated and labeled: brain (br), heart (h), stomach (st), intestine (in), and urinary bladder (bl). In both models, high activity is visible in the bladder (bl) and brain (br). A significant comparative finding is the high 2-FDG retention in the stomach (st) of the Glut2–/– mice (indicated by intense red/orange coloration) compared to the wild-type, suggesting impaired gastric emptying or altered glucose transport. The scans illustrate the physiological processes of gastric emptying and intestinal absorption, emphasizing the role of GLUT2 in glucose pharmacokinetics and metabolic distribution.
| Disaccharide | Enzyme | Products |
|---|---|---|
| Maltose / maltotriose | Maltase-glucamylase | Glucose + Glucose |
| Sucrose | Sucrase | Glucose + Fructose |
| Lactose | Lactase | Glucose + Galactose |
| Trehalose | Trehalase | Glucose + Glucose |
| alpha-limit dextrins | Isomaltase | Glucose units |

| Monosaccharide | Apical Transporter | Mechanism | Basolateral Transporter |
|---|---|---|---|
| Glucose | SGLT1 | Secondary active (Na+-coupled) | GLUT2 |
| Galactose | SGLT1 | Secondary active (Na+-coupled) | GLUT2 |
| Fructose | GLUT5 | Facilitated diffusion | GLUT2 |
In ors why salt is added and whats the role os water in this absorp on monosaccharide
SGLT1 on the enterocyte brush-border membrane cotransports 1 glucose (or galactose) molecule together with 2 Na+ ions simultaneously into the cell.
Na+/K+-ATPase (basolateral)
↓ pumps Na+ OUT of cell
↓ creates low intracellular Na+
↓ creates Na+ electrochemical gradient across apical membrane
↓
SGLT1 uses this gradient to pull Na+ INTO the cell
↓ glucose is dragged along with it (cotransport)
Each monosaccharide molecule transported by SGLT1 brings along approximately 264 molecules of water.
| Component | Reduced-Osmolarity ORS (WHO 2004) | Role |
|---|---|---|
| Glucose (anhydrous) | 13.5 g/L (75 mmol/L) | Drives SGLT1, carries water |
| Sodium chloride | 2.6 g/L → Na+ 75 mmol/L | Provides Na+ for cotransport |
| Potassium chloride | 1.5 g/L → K+ 20 mmol/L | Replaces K+ lost in diarrhea |
| Trisodium citrate | 2.9 g/L → citrate 10 mmol/L | Corrects acidosis |
| Total osmolarity | 245 mOsm/L | Slightly hypotonic to plasma |
Lumen Enterocyte Blood
| | |
| Glucose + 2Na+ → SGLT1 → glucose+Na+ in |
| + ~264 H2O ─────────────────────────────► |
| | Na+/K+-ATPase |
| | pumps Na+ out ──►|
| | GLUT2: glucose ──►|
| | H2O follows ────►|